Invention Grant
- Patent Title: Use of K2P potassium channel activators as antalgics
- Patent Title (中): 使用K2P钾通道激活剂作为止痛药
-
Application No.: US13497353Application Date: 2010-09-21
-
Publication No.: US09448242B2Publication Date: 2016-09-20
- Inventor: Alain Eschalier , Jéröme Busserolles , Abdelkrim Alloui , Michel Lazdunski
- Applicant: Alain Eschalier , Jéröme Busserolles , Abdelkrim Alloui , Michel Lazdunski
- Applicant Address: FR Clermont Ferrand
- Assignee: UNIVERSITE D'AUVERGNE CLERMONT I
- Current Assignee: UNIVERSITE D'AUVERGNE CLERMONT I
- Current Assignee Address: FR Clermont Ferrand
- Agency: Stites & Harbison. PLLC.
- Agent Stephen J. Weyer, Esq.
- Priority: FR0956477 20090921
- International Application: PCT/FR2010/051968 WO 20100921
- International Announcement: WO2011/033241 WO 20110324
- Main IPC: G01N33/68
- IPC: G01N33/68
Abstract:
The present invention relates to treating and preventing pain. More particularly the present invention demonstrates the involvement of K2P potassium channels in the antalgic effect of morphine. The present invention therefore provides a screening method for identifying antalgics.
Public/Granted literature
- US20120260354A1 Use of K2P Potassium Channel Activators as Antalgics Public/Granted day:2012-10-11
Information query
IPC分类:
